ET陷:对于产前的潜在治疗方法
1ET-traps, Cambridge, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, UK; Accelerate Cambridge, Judge Business School, University of Cambridge, UK; Imperial College London, UK.
Drug discovery today
|September 24, 2023
概括
内甲素-1 (ET-1) 在孕前中起作用. ET-traps是一种新型疗法,有效地结合ET-1,减少疾病标志物而无毒性,为孕前提供潜在的治疗方法.
科学领域:
- 心血管生物学 心血管生物学
- 生殖医学 生殖医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 升的内衣林-1 (ET-1) 与孕前的发病有关.
- ET-1有助于高血压,氧化应激和子宫前时的器官损伤.
研究的目的:
- 探索ET-traps在产前的治疗潜力.
- 评估ET陷在缓解产前相关病理方面的有效性和安全性.
主要方法:
- ET陷,设计为Fc融合蛋白模仿ET-1受体.
- 评估ET-trap结合亲和力和高ET-1的封存.
- 对ET-trap对孕前标志物和毒性影响的评估.
主要成果:
- ET陷显示出强大的结合和封存病态ET-1.
- 观察到关键妊娠前标志物显著减少.
- 没有观察到与ET-trap管理相关的毒性.
结论:
- ET-traps显示出前症的新疗法战略的希望.
- 用ET-traps针对ET-1可以有效地管理孕前症状和并发症.
- 该疗法提供了一种安全有效的方法,以减少孕前的疾病负担.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
191
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
191
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
507
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
507
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
552
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
552


